𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Regional pulmonary function in metastatic carcinoma to the lung studied with xenon-133

✍ Scribed by M. Khalil Ali,; Clifton D. Howe; John M. Miller


Publisher
John Wiley and Sons
Year
1971
Tongue
English
Weight
668 KB
Volume
27
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Lung function was studied in 21 patients with nodular pulmonary metastases. Routine pulmonary function studies demonstrated that reduction in vital capacity and arterial PO,, related to the degree of tumor involvement, are characteristic features of metastatic lung disease. The reduced arterial PO, is largely explained by increased right to left shunt. Regional pulmonary function studied with xenon-133 and 8 scintillation detectors revealed frequent ventilatory defects in the vicinity of single metastases. In patients with multiple bilateral metastases, defects in pulmonary blood flow and ventilation were commonly observed in the vicinity of the tumor masses.

HERE ARE FEW REPORTS ON THE EFFECTS OF

T pulmonary metastases on lung func-tion16. l o and none have dealt with regional pulmonary function. This study describes regional pulmonary ventilation and perfusion in patients with single and multiple modular metastatic lesions. Abnormalities of overall pulmonary function and zonal pulmonary function defects were correlated with the extent of the metastatic lesions.


πŸ“œ SIMILAR VOLUMES


Pilot study of regional, hepatic intra-a
✍ Luis H. Camacho; Razelle Kurzrock; Alex Cheung; Diane F. Barber; Sanjay Gupta; D πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 225 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Approximately 25% of patients with metastatic breast carcinoma develop hepatic involvement during the course of their disease that further affects their survival. Systemic paclitaxel is safe and has demonstrated good antitumor activity against breast carcinoma. The objec

The addition of cisplatin to cyclophosph
✍ Thierry Urban; Claude Chastang; FranΓ§ois-Xavier Lebas; Jean-Paul Duhamel; Guy Ad πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 2 views

## BACKGROUND. To assess whether the addition of cisplatin (100 mg/m 2 administered intravenously on Day 1) to CDE (cyclophosphamide [1000 mg/m 2 on Day 1], doxorubicin [45 mg/m 2 on Day 1], and etoposide [150 mg/m 2 on Days 1 and 2] combination is useful in the treatment of patients with small cel